|Bid||123.00 x 800|
|Ask||125.11 x 800|
|Day's Range||121.38 - 126.64|
|52 Week Range||35.25 - 141.90|
|Beta (5Y Monthly)||1.89|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 09, 2021 - Feb 15, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||150.43|
Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors to participate by webcast.
Instead of investing in the company that would have made you a millionaire years ago, seek out the ones that have the potential from here.
Exact Sciences look set to have a three-weeks-tight pattern. The company is one of several working on liquid biopsies, with blood tests that can detect multiple cancers. It's the subject of our IBD Cover story this week.